1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

OmniActive Acquires ENovate Biolife to Strengthen Its Position in the Dietary Supplement Space

07 Nov 2024
Admin
News Article

OmniActive Acquires ENovate Biolife to Strengthen Its Position in the Dietary Supplement Space

Overview

OmniActive Health Technologies has acquired ENovate Biolife, a developer of proprietary, clinically researched botanical ingredients for health solutions. This deal, funded through internal accruals, has further strengthened the company’s commitment to providing high-quality, scientifically validated health ingredients to consumers globally.

OmniActive: a Leader in Industry

With advanced encapsulation technologies that enhance ingredient solubility, stability, and bioavailability, TA Associates-backed OmniActive has established itself as a leader in differentiated, safe, and effective dietary supplement solutions.
Looking ahead, the company aims to double its top line, targeting Rs. 2,000 crores within the next 5 to 6 years from the present Rs. 1,000 crores.
The acquisition is expected to contribute in achieving this growth.

Strategic Expansion

This transaction marks OmniActive’s second strategic expansion, following its purchase of Bengaluru-based botanical ingredients company IndFrag in 2017.

Words from the MD: OmniActive

"ENovate's approach to ingredients perfectly aligns with OmniActive's mission of delivering proven products that make a meaningful difference in consumers' lives," said Sanjaya Mariwala, executive chairman and managing director, OmniActive.
"This acquisition is in line with our long-term growth strategy of diversifying product portfolios, accessing new customers and technologies and expanding our presence to new geographies. ENovate has done a remarkable job bringing multiple standout ingredients to the market including Muvz, RedNite, and the award-winning Oxyjun,” he added.

Words from the CEO: ENovate

"We are extremely proud of the strides we have made to help our loyal customers deliver products formulated with clinically backed ingredients to address consumer health and performance needs,"" said Jayesh Chaudhary, founder and CEO, ENovate.
"OmniActive's comprehensive capabilities spanning across clinical research, R&D, regulatory, marketing and operations, along with global reach, position us well to elevate these ingredients even further,” he said.

About the Partnership

OmniActive’s partnership with ENovate began in 2019 with a US licensing agreement for enXtra, a clinically studied mental energy ingredient.
This successful collaboration led to a global expansion, with enXtra now widely commercialised by numerous premium brands worldwide.